Daniel L Jacoby

17PUBLICATIONS
109CO-AUTHORS
Cardiology (incl. cardiovascular diseases)PharmacogenomicsEpidemiological modellingAllergyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 29, 2026
Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

|Aug 28, 2026
Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM.

|May 08, 2026
Towards a Quantitative Understanding of Aficamten Clinical Pharmacology: Pharmacokinetic-Cardiodynamic Modeling to Support Safety and Efficacy.

|Dec 05, 2025
Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM.

Juan Pablo Kaski, Paul F Kantor, Stephanie J Nakano

|Sep 05, 2025
Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial.

Joseph Campain, Catharine Griskowitz, Chloe Newlands

|Sep 01, 2024
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.

Caroline J Coats, Ahmad Masri, Roberto Barriales-Villa

Pageof 3

Frequent Collaborators

6 joint publications

Stephen B Heitner

6 joint publications

Carolyn Y Ho

6 joint publications

Stuart Kupfer

5 joint publications

Fady I Malik